July 23 (Reuters) - Valeant Pharmaceuticals International Inc VRX.TO :
* Commonwealth Laboratories, Inc. announces agreement with Valeant
Pharmaceuticals for the acquisition of commonwealth's U.S. and Canadian
business
* Commonwealth laboratories - commonwealth's existing management team will
remain in place
* Commonwealth laboratories - deal provides for an up-front purchase price to
be paid by Valeant on closing
* Commonwealth laboratories - deal provides for opportunity for additional
sales-based milestones payments
* Source text for Eikon ID:nBwc838hma
* Further company coverage VRX.TO